CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Statistics

Total Valuation

CNSP has a market cap or net worth of $3.82 million. The enterprise value is -$6.04 million.

Market Cap	3.82M
Enterprise Value	-6.04M

Important Dates

The last earnings date was Monday, November 17, 2025, before market open.

Earnings Date	Nov 17, 2025
Ex-Dividend Date	n/a

Share Statistics

CNSP has 574,580 shares outstanding.

Current Share Class	574,580
Shares Outstanding	574,580
Shares Change (YoY)	n/a
Shares Change (QoQ)	+50.99%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	4.26%
Float	540,540

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.00.

Current Ratio	5.81
Quick Ratio	5.03
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-863.74

Financial Efficiency

Return on equity (ROE) is -197.11% and return on invested capital (ROIC) is -123.84%.

Return on Equity (ROE)	-197.11%
Return on Assets (ROA)	-85.59%
Return on Invested Capital (ROIC)	-123.84%
Return on Capital Employed (ROCE)	-133.20%
Revenue Per Employee	n/a
Profits Per Employee	-$2.61M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.38% in the last 52 weeks. The beta is 0.45, so CNSP's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-89.38%
50-Day Moving Average	8.25
200-Day Moving Average	16.06
Relative Strength Index (RSI)	38.49
Average Volume (20 Days)	17,999

Short Selling Information

The latest short interest is 17,700, so 3.08% of the outstanding shares have been sold short.

Short Interest	17,700
Short Previous Month	45,735
Short % of Shares Out	3.08%
Short % of Float	3.27%
Short Ratio (days to cover)	0.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.20M
Pretax Income	-13.07M
Net Income	-13.07M
EBITDA	-13.20M
EBIT	-13.20M
Earnings Per Share (EPS)	-$41.85

Balance Sheet

The company has $9.86 million in cash and $30,793 in debt, giving a net cash position of $9.83 million or $17.11 per share.

Cash & Cash Equivalents	9.86M
Total Debt	30,793
Net Cash	9.83M
Net Cash Per Share	$17.11
Equity (Book Value)	9.91M
Book Value Per Share	17.25
Working Capital	9.43M

Cash Flow

In the last 12 months, operating cash flow was -$16.23 million and capital expenditures -$4,188, giving a free cash flow of -$16.23 million.

Operating Cash Flow	-16.23M
Capital Expenditures	-4,188
Free Cash Flow	-16.23M
FCF Per Share	-$28.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-344.68%
FCF Yield	-428.10%

Analyst Forecast

The average price target for CNSP is $20.00, which is 200.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	200.86%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-51.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 22, 2025. It was a reverse split with a ratio of 1:12.

Last Split Date	Jul 22, 2025
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1